References

Adib ZM, Ghanbarzadeh S, Kouhsoltani M, Khosroshahi AY, Hamishehkar H (2016) The effect of

particle size on the deposition of solid lipid nanoparticles in different skin layers: a histological

study. Adv Pharm Bull 6:31–36. https://doi.org/10.15171/apb.2016.006

Arlian LG (1989) Biology, host relations, and epidemiology of Sarcoptes scabiei. Annu Rev

Entomol 34:139–159. https://doi.org/10.1146/annurev.en.34.010189.001035

Banga AK, Bose S, Ghosh TK (1999) Iontophoresis and electroporation: comparisons and

contrasts. Int J Pharm 179:1–19. https://doi.org/10.1016/S0378-5173(98)00360-3

Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery.

Eur J Pharm Sci 14:101–114. https://doi.org/10.1016/S0928-0987(01)00167-1

Barry BW (2002) Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev 54:31–40.

https://doi.org/10.1016/S0169-409X(02)00113-8

Beg S, Raza K, Kumar R, Chadha R, Katare OP, Singh B (2016) Improved intestinal lymphatic

drug targeting via phospholipid complex-loaded nanolipospheres of rosuvastatin calcium. RSC

Adv 6:8173–8187. https://doi.org/10.1039/c5ra24278a

Benfeldt E, Hansen SH, Vølund A, Menné T, Shah VP (2007) Bioequivalence of topical

formulations

in

humans:

evaluation

by

dermal

microdialysis

sampling

and

the

dermatopharmacokinetic method. J Invest Dermatol 127:170–178. https://doi.org/10.1038/sj.

jid.5700495

Bhat R (2012) Pyoderma gangrenosum: an update. Indian Dermatol Online J 3:7. https://doi.org/10.

4103/2229-5178.93482

Brown SJ (2017) Molecular mechanisms in atopic eczema: insights gained from genetic studies. J

Pathol 241:140–145. https://doi.org/10.1002/path.4810

Brown MB, Martin GP, Jones SA, Akomeah FK (2006) Dermal and transdermal drug delivery

systems: current and future prospects. Drug Deliv 13:175–187. https://doi.org/10.1080/

10717540500455975

Table 14.5 List of drugs in the clinical trial for skin care

Drug

Identifier

Title

Year

of

filling

Clinical

trial

phase

Anthralin

NCT03348462

Formulation and clinical evaluation of

ethosomal and liposomal preparations

of anthralin in psoriasis

2017

Phase 4

Meglumine

antimoniate

NCT01050777

Efficacy of topical liposomal form of

drugs in cutaneous leishmaniasis

2010

Early

phase 1

Retinyl

palmitate

NCT04080869

Formulation of retinyl palmitate-

loaded topical ethosomes for

treatment of acne vulgaris: a split-face

comparative clinical study

2019

Phase 2

Amphotericin-

B

NCT02656797

Topical liposomal amphotericin B gel

treatment for cutaneous leishmaniasis

2018

Phase 2

HL-009

NCT01568489

A randomized, phase 2, double-blind,

placebo-controlled trial to evaluate the

safety and efficacy of HL-009

liposomal gel in adult patients with

mild to moderate atopic dermatitis

2012

Phase 2

226

R. K. Paul et al.